FidoCure® Veterinary Team Blog

Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates from our team of experts and advisors

FidoCure® Precision Medicine Data Showcased at the American Association of Cancer Research (AACR)

At the AACR 2023 annual meeting,  Dr. Lucas Rodrigues, Head of Veterinary Research at FidoCure®, presented the results of two innovative studies which demonstrated the power of real-world data from dogs with cancer to drive drug development strategies and inform human clinical trials.

The first study, titled "High frequency of TP53 mutations in canine skin tumors recapitulates solar induced human lesions representing an important research model of spontaneous diseases," focused on the similarities between skin tumors in dogs and humans caused by sun exposure. The study found a high frequency of TP53 mutations in canine skin tumors, mirroring those seen in humans with solar-induced skin lesions. This validates the use of dogs as a valuable research model for spontaneous diseases.

Read More

World Veterinary Day Interview: Strengthening Veterinary Resilience

Resilience is defined as the capacity to recover quickly from difficulties and toughness-- there are both physical and psychological resilience. Both have been severely tested these last few years with the pandemic, the current war, national divisions, etc. and have really affected veterinarians in the world at large.

Read More

Rising Women in Veterinary Oncology

An introduction from Chief Medical Officer, Dr. Gerry Post

Veterinary medicine is changing. I remember one of my first days in veterinary school looking at the class pictures that were hung in the hallways. I remember seeing the first woman in one of these class photos and noting that she was still practicing.

Read More